Expiration Date: 12/05/2024
Learner Notification

*Please note that you must complete the Post Webinar Evaluation (link below) to receive CE credit.

Jennifer Ross, MD
Associate Director of Fellowship Training and Instructor of Pediatrics
Division of Addiction Medicine, Harvard Medical School
Has disclosed no relevant financial relationships

Abby Montague, MD
Medical Toxicologist and Pediatric Hospitalist
Children's Minnesota
Has disclosed no relevant financial relationships

David Vearrier, MD, MPH
Professor of Emergency Medicine
University of Mississippi Medical Center
Has disclosed no relevant financial relationships


This session will provide background on the use of N-acetyl-cysteine in the treatment of cannabis use disorder in adolescents and current recommendations.

Acknowledgement of In-Kind Commercial Support

No in-kind commercial support was received for this educational activity.

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available.  If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Physicians and Pharmacists

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Academy of Clinical Toxicology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM for physicians and 1 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.

Objectives - After attending this program you should be able to:

  1. Describe the effects of cannabis on the developing brain.
  2. Discuss screening for substance use disorders in adolescents and young adults.
  3. ​​Understand the utilization of N-acetylcysteine in the treatment of adolescents with cannabis use disorders.

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.


Click here to complete the Post Webinar CE Evaluation